Post on 12-Feb-2016
description
1 Platelets use Oxygen to form Lipid Regulators while
Endothelial cells form NO
A) Platelet function:i. Blood clotting and stroke (anticoagulant drugs) ii. Prostaglandin and thromboxane formation from
polyunsaturated fatty acidsiii. Nutritional approach to prevent heart diseaseiv. COX Inhibitors (NSAIDs) (antiplatelet drugs)
B) Endothelial cell functions: Prostacyclin and plasminogen
activator formationRole of endothelial cells in regulating blood pressure:
- Angiotensin and EDRFNitric oxide formation, signaling and toxicity:
- Use of Nitric Oxide generators: (vasodilator / antihypertensive drugs)
2
Plateletst1/2 = 4 days Fragments of Megakaryocytes of bone marrow Contain: glycogen granules Mitochondria Lysosomes No nucleus, DNA, protein synthesis.1) dense granules – ADP, ATP, serotonin (5HT)2) granules contain clotting factors and PDGF (platelet derived growth factor) 80% ATP from glycolysis and 20% from mitochondria
3
Platelet Function is to plug blood leaks (blood clotting) Activated by collagen (damaged vascular surface) or thrombin which binds to receptors. Platelet disc shape changes to sphere i.e. swell, form pseudopods, become sticky and attach to collagen
Resting platelets Activated PlateletsImages From: http://www-personal.engin.umich.edu/~tkinzer/
4
Mechanism of platelet aggregation to form a clot
ADPreleasedfrom plateletgranule
receptor
Ca2+ influxin other platelets
MembranePhospholipaseA2 activated
Phospholipid
Arachidonate
cyclooxygenaseacetylates
Aspirin(drug)
PGH2
Thromboxane A2 (TxA2)
Diacylglycerol (DAG)+ inositol triphosphate (IP3)
PhosphatidylinositolMembrane Phospholipase C
collagenreceptor
COLLAGEN
TxA2 synthetasedrug?
receptor
Ca2+ InfluxContraction
of microtubules
Granulerelease
PLATELETAGGREGATION
2O2
5
Modified from Fig. 10.37, Stryer (5th ed).A fibrin clot (blood clot) is formed by the interplay of the intrinsic, extrinsic, and final common pathways.Intrinsic pathway:• initiated when factor XII is activated by contact with abnormal surfaces due to injury.Extrinsic pathway:• triggered by trauma, which activates factor VII which releases tissue factor.
Fibrin clot formed by zymogen activation cascadeINTRINSIC PATHWAY
Traps aggregatedplatelets
6Anticoagulant drugs (stroke treatment prevents new clots).• Vitamin K is essential for prothrombin synthesis (and other clotting
factors).• Abnormal prothrombin is formed (does not bind Ca2+) in the absence
of Vit. K or in the presence of Vit. K antagonists (see below).
O
O
CH3
CH3
H
6
Vitamin K
OO
OH
C
O O
OH
H
H
O
OO
OH
CH
CH3
Dicoumarol- Spoiled sweet clover causes fatal hemorrhagic disease in cattle.
Warfarin for thrombosis but high CYP2C9 polymorphism.Drug name Coumadin (rat poison)
Anticoagulants Drugs – Vit. K antagonists
2-3 days before it works DONT admin. again for 3d
Drug induced thrombocytopenia• Life threatening platelet depletion caused by drug or
heparin induced antibodies which bind to platelet factor 4 complex. This is not associated with immune memory.
• Hemorrhage, bruising, brain, nose bleeds, stools• Drugs heparin, quinine, antimicrobials, NSAIDs, penicillin, ranitidine, furosemide
7
8Platelets Repair Broken Blood Vessel
a. Platelets secrete platelet derived growth factor (PDGF): a growth factor migration and division of vascular endothelial cells, smooth muscle cells, fibroblasts REPAIR OF DAMAGED VASCULAR WALLS b. MEMBRANE ACTIN AND MYOSIN CONTRACT platelet attached to fibrin are retracted CLOT RETRACTS edges of broken blood vessel are pulled together
c. Platelets collected and stored for use in surgeries , transplants and cancer therapy to stop bleeding.
9
Prostaglandin and thromboxane synthesis stages1. Membrane Phospholipid Containing a Glycerol Backbone and a Fatty Acid at the First Position, b Arachidonic Acid at the Second Position c Polar Phospholipid Moiety at the Third Position.
10
Biochemical Structure of Typical Fatty Acids Incorporated Into Membrane
Phospholipids
PGE1
PGE2
PGE3
11 Overview of Cyclooxygenase (COX) Pathways
Cellular Phospholipid
Free Arachidonic Acid
Prostaglandin H
Prostaglandins
Phospholipase A2
PG H Synthase
ProstacyclinSynthase
ENDOTHELIAL CELL
Prostacyclins
TX Synthase
Thromboxanes
PLATELET
PG Synthases
12
Conversion of Arachidonic Acid to PGD2, PGF2, PGE2
Prostaglandin synthase consists of cyclooxygenase (COX) and peroxidase
COOHO
O
COOH
OOH
O
O
COOH
OH
OH
O
COOH
OH
OH
OH
COOH
OH
OH
O
COOH
OH
Arachidonate
CYCLOOXYGENASE
2O2
AspirinIndomethacin
Ibuprofen
PGG2
PEROXIDASE
Drugs, Carcinogens
Oxidised (Toxic)*
*
PGH2
PGE2
PGF2
PGD2
ISOMERASE
ISOMERASE
REDUCTASE
Cyclooxygenase
_
Peroxidase
Isomerase
Reductase
Isomerase
* NSAID now used as prophylaxis to prevent colon carcinogenesis
Toxin prev. by NSAIDs e.g. Colon cancer
NSAIDs
13
Prostaglandin and Prostacyclin and Heart Disease
O
O
COOH
OHPGH2 Prostaglandin H2
Endothelial Cells
COOH
OH
O
PGI2 ProstacyclinCOOH
OH
O
O
Platelets
Prevents Platelet Aggregation
TXA2 Thromboxane A2 COOH
OH
O
Causes Platelet Aggregation
TXB2 Thromboxane B2
H2O
OH
HO
OH
14
UnstauratedFatty AcidFormation
-Linolenic acid (LNA)
Stearidonic Acid (SDA)
Eicosatetraenoic acid
Eicosapentaenoic Acid
(EPA)
Series 3 Prostaglandins
Series 1 Prostaglandins
Series 2 Prostaglandins
Arachidonic Acid
Dihomogamma Linolenic acid
(DGLA)
-Linolenic Acid (GLA)
Linoleic Acid (LA)
Delta-6- Desaturase
Elongase
Delta-5- Desaturase
Essential Fatty Acids From the diet
OMEGA-3 OMEGA-6
18:3 18:2
CH3 CH3CH3 CH3
15
COX-1 (ALL CELLS) COX-2 (INFLAMMATORY CELLS) Physiological Function – all cells - PG’s cytoprotective (stomach, kidney) - TXA platelet (clotting function)
Inflammatory cells (also brain) - mediate inflammation and pain - inducible by cytokines, mitogens,
endotoxins (contributes to rheumatoid arthritis)
- promote colon cancer by preventing apoptosis
- causes premature labour Inhibitors - aspirin, NSAIDS, antithrombosis drugs but cause gastric/renal lesions
Inhibitors - selective NSAIDS e.g. nimesulide - chemoprevention/colon cancer - antipyretic (knockout mice – infertile
females, no intestinal polyps)
Antiplatelet drugs Cyclooxygenase (COX) and COX inhibitors (NSAIDs)
Colon cancer prevented by low daily doses of aspirin or COX inhib.
• Aspirin inhibits COXI which catalyse the peroxidase activation of environmental arylamines to human carcinogens e.g. benzidine,naphthylamine. Azoxymethane rodent colon carcinogen.
• COX2 activity & extracellular matrix metalloproteinases is induced by inflammation or colorectal cancer (CRC).
• Inhibitors of these enzymes decrease CRC metastasis Diseases Colon Rectum 51,342-347(2008)
16
17 NSAIDSCOX-1 inhibitors bind COX enzyme (prevents PGE formation) GI toxicity as PGE protects intestinal mucosa
1) Aspirin - irreversible - acetylates Ser 530, prevents arachidonic acid binding2) Mefenamate, Ibuprofen - reversible, competitive with fatty acid binding .3) Flurbiprofen - slow binding (salt bridge) competitive inhibition by
binding in the hydrophobic channel4) Indomethacin - non-selective - binds deepest in hydrophobic channel(incr. risk of hypertension, congestive heart failure unlike Celecoxib)
COX-2 inhibitors on the market – much less GI toxicity 4) Celecoxib (celebrex). Vioxx withdrawn
18
Role of endothelial cells in regulating blood pressure
andNitric oxide formation, signaling
and toxicity
19
1) Angiotensin converting enzyme (inhibited by specific dipeptides) used to lower blood pressure. Captopril*25-50mg (but agranulocytosis risk, cough), Enalapril*1-20 mg. Ramipril 2.5-20 mg (10mg also for preventing cardiovascular/stroke in diabetics.
Function of Endothelial cells (line vessel walls)
Angiotensin converting enzyme formation and actionAngiotensinogen (411 aa) synthesised in the liver Plasma
renin (synthesised in kidney, a protease)
Angiotensin I in plasma (10aa)
2aa
angiotensin converting enzyme(endothelial cells) (therefore a dipeptidase)
ACE inhibitors
Angiotensin II in plasma (8 aa)
Vasoconstrictor
blood pressure
20
Intracellular endothelial cell activity
4) Monoamine oxidase plasma norepinephrine or serotonin
5) Thromboplastin synthesis and secretion (activated state) initiate blood clotting (extrinsic pathway)
6) Synthesis and secrete plasminogen activators (resting state) initiates clot fibrinolysis
Endothelial cells (line vessel walls)
2) ATPase and 5’-nucleotidase degrade ATP and ADP
3) Inactivate prostaglandins E and F and leukotrienes C4 and D4
Cell surface extracellular activity – (cont.)
21
Synthesis and Secretion of Plasminogen Activators (Resting State) initiate Clot Formation (reversed by clot
busters” e.g.plasmin & plasminogen activator)Stroke Therapy (Dissolve clots)
Plasminogen incorporated into
clot fibrin
Plasmin(a serine protease)
Fibrin
Plasminogen Activator*(a serine protease)Endothelial cell
CO
Dissolve fibrinTherefore activator
Fibrin-boundplasmin
Fibrinolysis
CO?
22 Stroke therapy (con’t)
Drug companies are using recombinant DNA technology to makePLASMINOGEN ACTIVATORS to reduce myocardial damagefollowing acute coronary thrombosis (but x 10 expensive and nobetter/safer.
Cigarette smoke CO damages endothelial cell
Prevent clotting e.g., stored blood
1. Complex Ca2+ with citrate or oxalate2. Heparin* helps remove thrombin (produced by mast cells)
23Endothelial cells (con’t)
7) PROSTACYCLIN* synthesis and release (resting state) (PGI2) prevents platelet aggregation
phospholipid arachidonicacid PGG2 PGI2
phospholipase A2PGI2 synthetaseprostaglandin
synthetase(cyclooxygenase)
Therefore endothelial cells function to prevent thrombosisProstacyclin synthase inhib. by COX2 inhibitor e.g. rofecoxib.
8) EDRF (i.e. nitric oxide, a vasodilator) formed from arginine
Plasma Membrane Activity
24EDRF - Endothelial Derived Relaxing Factor (NO).
i.e. acetylcholinerelaxes vascular smooth muscle only if endothelial cells are present.
ENDOTHELIAL derivedRELAXING FACTOR:- unstable andinactivated by oxygenand hemoglobin Local hormone - indentified as nitric oxide!
Endothelial cell regulation of blood pressurei.e. effect on smooth muscle cells
25Nitric Oxide Synthases (NOS)
Arginine (100 uM in blood, 2 mM in endothelial cells) - NO synthesized from citrulline Science 278, 425-431 (1997).
H2N CH C
CH2
OH
O
CH2
CH2
NH
C
NH2
NH
H2N CH C
CH2
OH
O
CH2
CH2
NH
C
NH2
N
H2N CH C
CH2
OH
O
CH2
CH2
NH
C
NH2
O
NOS NOS
OH
NADPH NADP+
O2 H2O
NADPH NADP+1/21/2
O2 H2O
Analogous to"P450 + reductase"
L-Arginine N-OH Arginine L-Citrulline
+ NO
26
4)
27
CH2ONO2
CHONO2
CH2ONO2
LiverNADPH microsomes
via reduced P450
NO2reduced by mitochondria NO
CH2OH
CHONO2
CH2ONO2
CH2ONO2
CH2OH
CH2ONO2
Glycerol
glucuronidatedurine
CO2
GSH GSHtransferase GSNO GSH
GSSG
NO
Vascular smooth musclecells and endothelial cells
Drugs that act by Generating Nitric Oxide (NO.)1) NITROGLYCERIN - antianginal, antihypertensive, vasodilator
Adverse effect: oxidative stress , HEADACHE unless tolerant Tolerance because vascular ALDH in mitochondria reduces NG but is inactivated.by peroxynitrite formed when NO reacts with O2
(formed when NO inhibits respiratory chain) (J.Clin.Invest.113,482-9(2004);J.Am.Coll.Cardiol.57,93-8(2011). Tolerance reversed antioxidants atorvastatin,carvediol,thiols,hydralazine,,HMG-CoA red.inhib.
28
“AMYL” NITRITE (i.e. isopentyl nitrite) - potent vasodilators which are inhaled (Roberts)
+ GSH transferase (GST 4-4)
CHCH2CH2H3C
H3C
ON O mitochondria
or P450 reductase-ONO
CHCH2CH2OHH3C
H3C
NOAmyl nitrite
GSHGSNO
GSH or reducingsystem
Nitrite anionradical
29
Amyl nitrite (con’t)
A) Prescription drug (except 1960-1969) In glass ampules enclosed in mesh - crushed in the fingers = popping sound. “Poppers” - inhaled to relieve angina.
B) Recreational inhalant (“locker room”) - Butyl nitrite aphrodisiac – used for enhancing sexual pleasure as nitrite induces vasodilation of the rectal mucosal muscles. but causes acute hemolysis if G6PDH deficient J.of Toxicol-Clin Toxicol.42,313-6(2004);J. Neuroimmunol.83, 157-61 (98)
C) Cyanide antidote - nitrite oxidises oxyhemoglobin to met- hemoglobin (Poison control centre) and then Fe3+ of methemoglobin complexes cyanide.